Literature DB >> 4126071

Hypercalcaemia after oral calcium-carbonate therapy in patients on chronic haemodialysis.

D S Ginsburg, E L Kaplan, A I Katz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4126071     DOI： 10.1016/s0140-6736(73)91292-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

Review 2.  [Hypo and hypercalcemia as an emergency].

Authors:  H G Haas; M A Dambacher; J Guncaga
Journal:  Klin Wochenschr       Date:  1975-05-15

3.  Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients.

Authors:  M Wallot; K E Bonzel; A Winter; B Geörger; B Lettgen; M Bald
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

Review 4.  Drug-induced electrolyte abnormalities.

Authors:  E P Brass; W L Thompson
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

5.  Severe hypercalcemia associated with hydrochlorothiazide and calcium carbonate therapy.

Authors:  R Hakim; G Tolis; D Goltzman; S Meltzer; R Friedman
Journal:  Can Med Assoc J       Date:  1979-09-08       Impact factor: 8.262

6.  Immobilization hypercalcaemia in patients on regular haemodialysis.

Authors:  G Drivas; M Ward; D Kerr
Journal:  Br Med J       Date:  1975-08-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.